Navigation Links
Phylonix to present at 2009 Society of Toxicology Annual Meeting
Date:3/10/2009

Cambridge, MA March 10, 2009 Phylonix Pharmaceuticals, Inc., the leading contract research organization for preclinical testing in zebrafish, will present data about the company's in vivo zebrafish-based assays at the 48th Society of Toxicology (SOT) Annual Meeting being held March 15-19 at the Baltimore Convention Center in Baltimore, Maryland. A podium presentation will be presented at SOT on Tuesday, March 17 and two posters will be presented on Monday, March 16 and Tuesday, March 17, respectively.

Podium Presentation
"Assessment of Ototoxicity and Otoprotection in a Zebrafish Hair Cell Model"

Tuesday, March 17, 10:36 am - 10:59 am, Room 308

Poster Presentations

"Assessment of Drug Induced Cardiotoxicity in Transparent Zebrafish"
Monday, March 16, 1:00 pm - 4:30 pm
390 Poster / Board 207

"Zebrafish: A Predictive Model for Assessing P-Glycoprotein Inhibitors"
Tuesday, March 17, 9:00 am-12:30 pm
983 Poster / Board 534

The company is exhibiting at ToxExpo in Booth 2950 from Monday, March 16 through Wednesday, March 18; and is also sponsoring a lunch hour workshop, "Zebrafish: A Predictive Model for Assessing Safety and Toxicity," on Monday, March 16 from 12:15 pm-1:15 pm. Space is limited and reservations are required. Please contact Kristine.karklins@phylonix.com or 617-441-6700 x312 to reserve your seat or for more information.


'/>"/>

Contact: Edward O'Lear
ed.olear@phylonix.com
617-441-6700
Phylonix Pharmaceuticals
Source:Eurekalert

Page: 1

Related biology news :

1. NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays
2. Understanding soil carbon sequestration: New book presents key concepts
3. World Congress on Osteoporosis 2010 presents outstanding scientific program
4. Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test
5. Clemson chemists present revolutionary teaching concepts
6. Ancestral genome of present-day African great apes & humans had burst of DNA sequence duplication
7. Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference
8. Hypertension and cholesterol medications present in water released into the St. Lawrence River
9. Sea bed provides information about present climatic change
10. David Rose to present Howe School lecture on new technologies and business models, Jan. 29
11. New manual presents robust, state-of-the-art proteomics methods for teaching and research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
Breaking Biology Technology: